5-Amino-1MQ — NNMT inhibition, dose, and what actually happened

N
Joined 2026
31 posts
3/18/2026 · 1344 views

5-Amino-1MQ is an NNMT inhibitor (nicotinamide N-methyltransferase). In theory inhibiting NNMT should spare SAM and NAD+ precursors and improve metabolic phenotype in adipose.

Ran 150 mg/day oral, 12 weeks. Body comp moved a little (probably within noise), energy subjectively good, labs didn't shift much. Is anyone running a higher dose or seeing clearer signal?

7 Replies

H
Joined 2025
205 posts
hexaclinicContributor
3/19/2026

150 mg is on the lower end of what people describe as effective. The 250-300 mg range shows up more often in the positive writeups. Whether that's a real dose-response or selection bias I genuinely don't know.

Q2 stack
  • CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
  • Ipamorelin · 200 mcg · pre-bed · sub-Q
  • BPC-157 · 500 mcg · 2x/day · sub-Q
S
Joined 2026
115 posts
3/19/2026

The NNMT inhibition story is well-supported mechanistically. The human-scale effect in healthy adults has basically no published data. In the rodent work the phenotype in obese models is clearer than in lean models, which might explain why your labs moved less than the marketing suggests.

M
Joined 2026
32 posts
motsc_opsMember
29d ago

Ran 300 mg/day for 8 weeks alongside MOTS-c. Can't isolate which was doing what, but subjectively the 5-Amino window felt 'metabolically on' — more energy during fasted training, faster recovery from HIIT.

N
Joined 2026
34 posts
28d ago

The 'fat loss peptide' framing in vendor marketing is ahead of the evidence. In obese rodents, yes. In lean humans, mostly no data. Don't expect dramatic body comp results at any dose if your starting phenotype isn't metabolically compromised.

A
Joined 2026
31 posts
26d ago

ApoB didn't move for me on 250 mg x 8 weeks either. The lipid story for 5-Amino is overstated in the bro-science writeups.

N
Joined 2026
31 posts
25d ago

Appreciating the reality check. Was going to bump to 300 — might pilot that for a 6-week block and report back.

D
Joined 2025
119 posts
dr_doubtRegular
23d ago

Before bumping the dose, consider whether your metabolic phenotype is the kind the compound actually targets. If you're already lean and insulin sensitive, you may just not have much room for NNMT inhibition to move things.

Sign in to reply.